Search
for
Sort by
Research 271–300 of 410
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Melatonin Exerts Prominent, Differential Epidermal and Dermal Anti-Aging Properties in Aged Human Eyelid Skin Ex Vivo
- Principles of chemotherapy
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- Oral minoxidil for late alopecia in cancer survivors
- Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?
- mTORC1 activity negatively regulates human hair follicle growth and pigmentation
- Telomere Dynamics and Telomerase in the Biology of Hair Follicles and their Stem Cells as a Model for Aging Research
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Management of Dermatologic Toxicities
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Cancer-Related Alopecia: From Etiologies to Global Management